The effects of pretreatment of mice with norethindrone on the metabolism of 14C-imipramine by the liver microsomal drug-metabolizing enzymes.
D000818:Animals; D002250:Carbon Radioisotopes; D002855:Chromatography, Thin Layer; D003035:Cobalt / Q000494:pharmacology; D003579:Cytochrome Reductases / Q000378:metabolism; D003574:Cytochrome c Group; D003640:Dealkylation; D003891:Desipramine / Q000378:metabolism; D005260:Female; D006863:Hydrogen-Ion Concentration; D006900:Hydroxylation; D007099:Imipramine / Q000378:metabolism*; D008748:Methylcholanthrene / Q000494:pharmacology; D051379:Mice; D008862:Microsomes, Liver / Q000201:enzymology / Q000378:metabolism*; D009249:NADP; D009640:Norethindrone / Q000494:pharmacology*; D010087:Oxides / Q000096:biosynthesis; D010634:Phenobarbital / Q000494:pharmacology; D011335:Proadifen / Q000494:pharmacology; D013997:Time Factors
D002250:Carbon Radioisotopes; D003574:Cytochrome c Group; D010087:Oxides; D003035:Cobalt; D009249:NADP; D008748:Methylcholanthrene; D011335:Proadifen; D003579:Cytochrome Reductases; D007099:Imipramine; D009640:Norethindrone; D003891:Desipramine; D010634:Phenobarbital